Neurogene Inc. - Common Stock — 재무제표 (NASDAQ:NGNE) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 210.52 M163.26 M115.95 M222.57 M335.73 M288.6 M 총 부채 19.3 M20.4 M21.62 M36.55 M25.36 M23.72 M 자본금 총액 191.22 M142.86 M94.33 M186.02 M310.38 M264.89 M 총 부채 및 주주자본 210.52 M163.26 M115.95 M222.57 M335.73 M288.6 M 총부채 —————— 순부채 ——————

뉴스

3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026 - TipRanks.com

1 Top Stock to Buy Now with 350% Upside, 3/24/2026, According to Top Analysts - TipRanks.com

Stifel sees rare disease stocks gaining after FDA official exit

Netflix, Dell among market cap stock movers on Friday

Why Is Neurogene Stock Skyrocketing Friday? - Neurogene (NASDAQ:NGNE)

뉴로진, FDA 혁신 치료제 지정에 30% 급등

Neurogene stock surges 30% on FDA breakthrough therapy status

FDA grants breakthrough therapy status to Neurogene’s Rett drug

스티펠, 뉴로진(Neurogene) 주식에 ’매수’ 등급 재확인

Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin

Neurogene doses multiple patients in Rett syndrome gene therapy trial

테이샤 유전자 치료제, Citizens "시장 수익률 상회" 등급 재확인